Word

OPTIPEG

Status

Dead

Status Code

602

Status Date

Monday, June 16, 2003

Serial Number

76179820

Mark Type

1000

Filing Date

Tuesday, December 12, 2000

Abandoned Date

Friday, April 25, 2003

Trademark Owner History

PolyMASC Pharmaceuticals Plc

Classifications

1 POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS; POLYMER BEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLS FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES, THERAPEUTIC AND DIAGNOSTIC AGENTS AND AS IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES, PROTEINS AND PEPTIDES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES; MICELLES AND MICELLE-LIKE STRUCTURES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES; POLYMER AGGREGATES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES; MICROEMULSIONS AND EMULSIONS FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL, VETERINARY AND COSMETIC PREPARATIONS AND SUBSTANCES; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF CARRIERS FOR THERAPEUTIC AND DIAGNOSTIC AGENTS; IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF LIPOSOMES, ANTIBODIES AND ANTIBODY FRAGMENTS TO BE USED AS THERAPEUTICS, DIAGNOSTICS, AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES; POLYMER BEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLS FOR USE IN THE MANUFACTURE OF LIPOSOMES, ANTIBODIES AND ANTIBODY FRAGMENTS TO BE USED AS THERAPEUTICS, DIAGNOSTICS, AND AS IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES, ANTIBODIES AND ANTIBODY FRAGMENTS FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF CARRIERS FOR THERAPEUTIC AND DIAGNOSTIC AGENTS

3 COSMETIC AND TOILETRY PRODUCTS CONTAINING POLYMER DERIVATIVES; NAMELY, EAU DE COLOGNE, PERFUMES, SHAVING SOAP, TALCUM POWDER, DENTIFRICES, TOOTHPASTE, ESSENTIAL OILS FOR PERSONAL USE, BATH OILS AND BATH SALTS, DEODORANTS FOR PERSONAL USE, SOAPS, SKIN CREAMS AND SKIN LOTIONS, MOISTURIZING CREAMS, BODY LOTIONS,AFTERSHAVE, LIPSTICK, MASCARA, EYELINER, SKIN CLEANSERS, MAKE-UP POWDERS AND CREAMS; NAIL POLISH; HAIRCARE PRODUCTS, NAMELY, HAIR SHAMPOO, CONDITIONER AND GEL;HAIR COLORANTS AND HAIR SPRAYS; MOUSSES AND BALMS FOR HAIR STYLING AND HAIR CARE

5 PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, PROTEINS, PEPTIDES, AMINO ACIDS AND THEIR DERIVATIVES, NAMELY, ANTIBODIES AND FRAGMENTS THEREOF; CYTOKINES AND DERIVATIVES OR FRAGMENTS THEREOF, NAMELY, THE INTERLININGS (IL), ESPECIALLY THE IL-i, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-b AND IL-li SUBTYPES THEREOF; COLONY STIMULATING FACTORS, NAMELY, GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR, GRANULOCYTE-COLONY STIMULATING FACTOR (ALPHA AND BETAFORMS) AND MACROPHAGE-COLONY STIMULATING FACTOR (ALSO KNOWN AS CSF-1); HAEMOPOIETINS, NAMELY, ERYTHROPOIETIN, HAEMOPOIETIN-ALPHA AND KIT-LIGAND (ALSO KNOWN AS STEM CELL FACTOR OR STEEL FACTOR); INTERFERONS (IFNS), NAMELY, IFNALPHA, IFNBETA, IFNGAMMA; GROWTH FACTORS AND BIFUNCTIONAL GROWTH MODULATORS, NAMELY, EPIDERMAL GROWTH FACTOR, PLATELET-DERIVED GROWTH FACTOR, TRANSFORMING GROWTH FACTOR (ALPHA AND BETA FORMS), AMPHIREGULIN, SOMATOMEDIN-C, BONE GROWTH FACTOR, FIBROBLAST GROWTH FACTORS, INSULIN-LIKE GROWTH FACTORS, HERAPIN BINDING GROWTH FACTORS AND TUMOR GROWTH FACTORS; DIFFERENTIATION FACTORS AND THE LIKE, NAMELY, MACROPHAGE DIFFERENTIATING FACTOR, DIFFERENTIATION INDUCING FACTOR (DIF) AND LEUKAEMIA INHIBITORY FACTOR; ACTIVATING FACTORS, NAMELY, PLATELET ACTIVATING FACTOR; COAGULATION FACTORS SUCH AS FIBRINOLYTIC/ANTICOAGULANT AGENTS INCLUDING HERAPIN AND PROTEASES AND THEIR PRO-FACTORS, NAMELY, CLOTTING FACTORS VII, VIII, IX, X, Xl, XII, ANTITHROMBIN III, PROTEIN C, PROTEIN 5, STREPTOKINASE, UROKINASE, PROUROKINASE,TISSUE PLASMINOGEN ACTIVATOR, FIBRINOGEN AND HIRUDIN; PEPTIDE HORMONES, NAMELY, INSULIN AND CALCITONIN; ENZYMES, NAMELY, SUPEROXIDE DISMUTASE, GLUCOCEREBRSIDASE, ASPARAGINASE AND ADENOSINE DEAMINASE; TRANSCRIPTION FACTORS AND TRANSCRIPTIONAL MODULATORS; CARBOHYDRATES, GLYCOSOAMINOGLYCANS, GLYCOPROTEINS AND POLYSACCHARIDES; LIPIDS, NAMELY, PHOSPHATIDYL-ETHANOLAMINE, PHOSPHATIDYLSERINE AND DERIVATIVES THEREOF; SPHINGOSINE; STEROIDS, NAMELY, CHOLESTEROL AND DERIVATIVES THEREOF; NUCLEOTIDES, NUCLEOSIDES, HETEROCYCLIC BASES, DNA, RNA, SYNTHETIC AND NON-SYNTHETIC OLIGONUCLEOTIDES INCLUDING THOSE WITH NUCLEASE RESISTANT BACKBONES; VITAMINS; ANTIBIOTICS; BACTERISTATIC AND BACTERICIDAL AGENTS;ANTIFUNGAL, ANTHELMINTHIC AND OTHER AGENTS EFFECTIVE AGAINST INFECTIVE AGENTS INCLUDING UNICELLULAR PATHOGENS; SMALL EFFECTOR MOLECULES, NAMELY, OPTIPEGNORADRENALIN, ALPHA ADRENERGIC RECEPTOR LIGANDS,DOPAMINE RECEPTOR LIGANDS, HISTAMINE RECEPTOR LIGANDS, GABA'BENZODIAZEPINE RECEPTOR LIGANDS, SEROTONICRECEPTOR LIGANDS, LEUKOTRIENES AND TRIIODOTHYRONINE; CYTOTOXIC AGENTS SUCH AS DOXORUBICIN, METHOTREXATE AND DERIVATIVES THEREOF; VACCINES, NAMELY, HEPATITIS-BVACCINE, MALARIA VACCINE, MELANOMA VACCINE AND HIV-1 VACCINE; BLOOD GROWTH AND GENE THERAPY PRODUCTS INCLUDING VIRAL VECTORS AND VIRUSES FOR ONCOLYSIS;PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, LIPIDS, NAMELY, PHOSPHATIDYL ETHANOLAMINE, PHOSPHATIDYLSERINE AND DERIVATIVES TTEREOF; SPHINGOSINE; STEROIDS; NAMELY, CHOLESTEROL AND DERIVATIVES THEREOF

10 CATHETERS; STENTS AND PARTS AND FITTINGS FOR THESE GOODS

35 TECHNOLOGY LICENSING SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY

42 RESEARCH AND CONSULTANCY SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY

Trademark Events

Jun 16, 2003

Abandonment - Failure To Respond Or Late Response

Oct 23, 2002

Inquiry As To Suspension Mailed

Sep 18, 2002

Assigned To Examiner

Apr 9, 2002

Letter Of Suspension Mailed

Oct 23, 2001

Correspondence Received In Law Office

Apr 23, 2001

Non-Final Action Mailed

Apr 6, 2001

Assigned To Examiner